DIM - Avail
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 100% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
1 Softgel(s)
Serving Size
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
100 mg
📊 Market median: 200.0mg (3 products)
📚 10 studies (Tier A: 1, B: 3)
Other Ingredients
Medium chain triglycerides
Mixed Tocopherols
yellow Beeswax
canola lecithin oil
Gelatin
Glycerine
purified Water
Annatto
Label Claims — Verification
❓
All Other
All Other (96% of products)
Structure/Function (88% of products)
Nutrient (2% of products)
No Claim (1% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Product Information
📋 Directions for Use
Recommended Use: As a dietary supplement, take one softgel per day with a meal, or as directed by your health care practitioner.
⚠️ Warnings & Precautions
KEEP OUT OF REACH OF CHILDREN.
🧪 Formulation Notes
Does not contain gluten.
Additional Information
Notice: Color, size or shape may appear different between lots.
DIM060-1
For Professional Use Only
Guaranteed GMP COMPLIANT Products
MADE WITH NON-GMO INGREDIENTS
STORE IN A COOL, DRY PLACE.
Product Details
UPC / SKU
8 79452 00123 7
DSLD Entry Date
2013-07-25
Product Type
Non-Nutrient/Non-Botanical
Form
Softgel Capsule
Brand
Designs for Health
DSLD ID
22639
Data Updated
2026-04-11
Research Evidence
5
Research Sources
44
Avg Quality Score
5
Rct
C
A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen
C
Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy
C
Effectiveness of 3,3'-Diindolylmethane Supplements on Favoring the Benign Estrogen Metabolism Pathway and Decreasing Body Fat in Premenopausal Women
D
Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer